Arbutus Historical Balance Sheet

ABUS Stock

USD 3.45 0.08 2.37%

Trend analysis of Arbutus Biopharma Corp balance sheet accounts such as Other Current Liab of 4.7 M, Total Current Liabilities of 27.2 M or Total Stockholder Equity of 93.5 M provides information on Arbutus Biopharma's total assets, liabilities, and equity, which is the actual value of Arbutus Biopharma Corp to its prevalent stockholders. By breaking down trends over time using Arbutus Biopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Arbutus Biopharma Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arbutus Biopharma Corp is a good buy for the upcoming year.

Arbutus Biopharma Inventory

(1.52 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

About Arbutus Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Arbutus Biopharma Corp at a specified time, usually calculated after every quarter, six months, or one year. Arbutus Biopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Arbutus Biopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Arbutus currently owns. An asset can also be divided into two categories, current and non-current.

Arbutus Biopharma Balance Sheet Chart

At this time, Arbutus Biopharma's Property Plant And Equipment Gross is comparatively stable compared to the past year. Short and Long Term Debt Total is likely to gain to about 10.5 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 4.7 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Arbutus Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Arbutus Biopharma Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Arbutus Biopharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Arbutus Biopharma Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Arbutus Biopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Arbutus Biopharma Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	20.5M	7.0M	8.1M	4.7M
Total Assets	195.4M	144.4M	166.1M	124.4M

Other Current Liab Total Assets

Arbutus Biopharma balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Short Long Term Debt Total	Short Term Debt	Other Liab	Net Tangible Assets
Total Assets		-0.11	0.05	1.0	0.13	-0.72	-0.04	0.76	0.96	0.39	0.73	-0.09	0.31	0.07	0.1	0.96	-0.1	0.26	0.97	-0.01	0.72	-0.22	0.2	0.64	0.97	0.9
Other Current Liab	-0.11		0.73	-0.12	0.03	0.1	-0.49	-0.11	-0.25	-0.28	0.3	0.22	0.4	0.51	0.42	-0.25	0.34	0.06	-0.08	0.13	0.31	0.03	-0.37	-0.4	-0.2	-0.03
Total Current Liabilities	0.05	0.73		0.03	0.05	0.15	-0.63	-0.06	-0.13	-0.32	0.41	0.28	0.71	0.85	0.71	-0.03	0.34	0.24	0.14	0.58	0.42	-0.1	-0.08	-0.17	0.01	0.25
Total Stockholder Equity	1.0	-0.12	0.03		0.14	-0.74	-0.03	0.77	0.96	0.43	0.73	-0.09	0.3	0.05	0.08	0.95	-0.09	0.27	0.95	-0.02	0.72	-0.23	0.19	0.62	0.95	0.9
Property Plant And Equipment Net	0.13	0.03	0.05	0.14		0.15	-0.68	-0.11	-0.01	0.05	0.47	-0.27	0.56	0.31	0.58	0.05	0.41	0.29	0.11	0.52	0.47	-0.18	-0.48	0.02	0.02	-0.12
Net Debt	-0.72	0.1	0.15	-0.74	0.15		-0.2	-0.99	-0.7	-0.27	-0.53	-0.06	0.01	0.2	0.38	-0.69	-0.03	-0.22	-0.64	0.36	-0.52	0.24	-0.24	-0.41	-0.69	-0.64
Retained Earnings	-0.04	-0.49	-0.63	-0.03	-0.68	-0.2		0.12	0.19	0.41	-0.55	-0.06	-0.92	-0.85	-0.83	0.07	-0.73	-0.28	-0.07	-0.8	-0.56	0.09	0.53	0.29	0.04	-0.01
Cash	0.76	-0.11	-0.06	0.77	-0.11	-0.99	0.12		0.72	0.25	0.58	0.04	0.11	-0.09	-0.28	0.73	0.09	0.27	0.69	-0.23	0.57	-0.26	0.26	0.45	0.73	0.71
Non Current Assets Total	0.96	-0.25	-0.13	0.96	-0.01	-0.7	0.19	0.72		0.43	0.52	-0.12	0.08	-0.13	-0.11	0.97	-0.31	0.13	0.93	-0.17	0.51	-0.12	0.29	0.67	0.96	0.87
Non Currrent Assets Other	0.39	-0.28	-0.32	0.43	0.05	-0.27	0.41	0.25	0.43		0.2	-0.35	-0.28	-0.45	-0.1	0.34	-0.44	0.2	0.26	-0.3	0.19	-0.28	0.3	0.48	0.27	0.29
Cash And Short Term Investments	0.73	0.3	0.41	0.73	0.47	-0.53	-0.55	0.58	0.52	0.2		0.0	0.68	0.45	0.52	0.61	0.39	0.5	0.72	0.31	1.0	-0.38	-0.08	0.36	0.62	0.64
Net Receivables	-0.09	0.22	0.28	-0.09	-0.27	-0.06	-0.06	0.04	-0.12	-0.35	0.0		0.05	0.16	-0.03	-0.17	0.2	-0.02	-0.07	0.05	0.02	0.04	0.15	-0.21	-0.09	-0.08
Common Stock Total Equity	0.31	0.4	0.71	0.3	0.56	0.01	-0.92	0.11	0.08	-0.28	0.68	0.05		0.92	0.85	0.2	0.66	0.43	0.33	0.83	0.69	-0.24	-0.39	-0.08	0.23	0.34
Common Stock Shares Outstanding	0.07	0.51	0.85	0.05	0.31	0.2	-0.85	-0.09	-0.13	-0.45	0.45	0.16	0.92		0.82	-0.02	0.61	0.27	0.13	0.87	0.46	-0.09	-0.34	-0.29	0.04	0.23
Short Term Investments	0.1	0.42	0.71	0.08	0.58	0.38	-0.83	-0.28	-0.11	-0.1	0.52	-0.03	0.85	0.82		0.01	0.47	0.36	0.15	0.8	0.53	-0.2	-0.33	-0.08	0.01	0.13
Non Current Liabilities Total	0.96	-0.25	-0.03	0.95	0.05	-0.69	0.07	0.73	0.97	0.34	0.61	-0.17	0.2	-0.02	0.01		-0.23	0.2	0.97	-0.08	0.59	-0.17	0.3	0.71	0.99	0.87
Other Current Assets	-0.1	0.34	0.34	-0.09	0.41	-0.03	-0.73	0.09	-0.31	-0.44	0.39	0.2	0.66	0.61	0.47	-0.23		0.21	-0.15	0.53	0.41	-0.08	-0.43	-0.34	-0.21	-0.08
Other Stockholder Equity	0.26	0.06	0.24	0.27	0.29	-0.22	-0.28	0.27	0.13	0.2	0.5	-0.02	0.43	0.27	0.36	0.2	0.21		0.23	0.26	0.5	-0.98	-0.28	0.21	0.19	0.21
Total Liab	0.97	-0.08	0.14	0.95	0.11	-0.64	-0.07	0.69	0.93	0.26	0.72	-0.07	0.33	0.13	0.15	0.97	-0.15	0.23		0.01	0.7	-0.17	0.25	0.66	0.97	0.89
Property Plant And Equipment Gross	-0.01	0.13	0.58	-0.02	0.52	0.36	-0.8	-0.23	-0.17	-0.3	0.31	0.05	0.83	0.87	0.8	-0.08	0.53	0.26	0.01		0.32	-0.1	-0.31	-0.24	-0.04	0.07
Total Current Assets	0.72	0.31	0.42	0.72	0.47	-0.52	-0.56	0.57	0.51	0.19	1.0	0.02	0.69	0.46	0.53	0.59	0.41	0.5	0.7	0.32		-0.38	-0.08	0.34	0.6	0.63
Common Stock	-0.22	0.03	-0.1	-0.23	-0.18	0.24	0.09	-0.26	-0.12	-0.28	-0.38	0.04	-0.24	-0.09	-0.2	-0.17	-0.08	-0.98	-0.17	-0.1	-0.38		0.21	-0.25	-0.15	-0.15
Short Long Term Debt Total	0.2	-0.37	-0.08	0.19	-0.48	-0.24	0.53	0.26	0.29	0.3	-0.08	0.15	-0.39	-0.34	-0.33	0.3	-0.43	-0.28	0.25	-0.31	-0.08	0.21		0.65	0.25	0.32
Short Term Debt	0.64	-0.4	-0.17	0.62	0.02	-0.41	0.29	0.45	0.67	0.48	0.36	-0.21	-0.08	-0.29	-0.08	0.71	-0.34	0.21	0.66	-0.24	0.34	-0.25	0.65		0.62	0.58
Other Liab	0.97	-0.2	0.01	0.95	0.02	-0.69	0.04	0.73	0.96	0.27	0.62	-0.09	0.23	0.04	0.01	0.99	-0.21	0.19	0.97	-0.04	0.6	-0.15	0.25	0.62		0.88
Net Tangible Assets	0.9	-0.03	0.25	0.9	-0.12	-0.64	-0.01	0.71	0.87	0.29	0.64	-0.08	0.34	0.23	0.13	0.87	-0.08	0.21	0.89	0.07	0.63	-0.15	0.32	0.58	0.88

Click cells to compare fundamentals

Arbutus Biopharma Account Relationship Matchups

Arbutus Biopharma balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	137.1M	204.5M	195.4M	144.4M	166.1M	124.4M
Other Current Liab	5.8M	7.3M	20.5M	7.0M	8.1M	4.7M
Total Current Liabilities	9.5M	11.2M	32.9M	22.5M	25.9M	27.2M
Total Stockholder Equity	102.0M	169.4M	136.9M	106.0M	121.9M	93.5M
Property Plant And Equipment Net	9.3M	8.1M	6.8M	6.1M	7.0M	4.8M
Net Debt	(49.3M)	(106.7M)	(28.6M)	(17.6M)	(15.8M)	(16.6M)
Retained Earnings	(1.0B)	(1.1B)	(1.2B)	(1.3B)	(1.1B)	(1.1B)
Cash	52.3M	109.3M	30.8M	26.3M	30.2M	39.9M
Non Current Assets Total	9.4M	43.8M	44.3M	12.4M	14.2M	13.5M
Non Currrent Assets Other	293K	44K	61K	103K	92.7K	88.1K
Cash And Short Term Investments	123.3M	155.3M	146.9M	126.0M	144.9M	73.6M
Net Receivables	1.3M	899K	1.4M	1.8M	2.0M	1.3M
Common Stock Total Equity	898.5M	985.9M	1.3B	1.3B	1.5B	1.6B
Common Stock Shares Outstanding	75.8M	106.2M	150.9M	166.0M	190.9M	200.4M
Short Term Investments	71.0M	46.0M	116.1M	99.7M	114.7M	120.4M
Liabilities And Stockholders Equity	137.1M	204.5M	195.4M	144.4M	166.1M	124.4M
Non Current Liabilities Total	25.6M	23.8M	25.7M	15.9M	18.3M	25.0M
Other Current Assets	6.2M	8.9M	2.9M	4.2M	4.9M	5.1M
Other Stockholder Equity	60.8M	65.5M	72.4M	81.3M	93.5M	98.1M
Total Liab	35.1M	35.0M	58.6M	38.4M	44.1M	31.0M
Property Plant And Equipment Gross	9.3M	8.1M	6.8M	18.0M	20.7M	21.7M
Total Current Assets	127.7M	160.7M	151.1M	132.0M	151.8M	76.6M
Common Stock	985.9M	1.3B	1.3B	1.3B	1.6B	1.4B
Short Long Term Debt Total	3.0M	2.6M	2.2M	8.7M	10.0M	10.5M
Short Term Debt	780K	766K	744K	425K	488.8K	464.3K
Other Liab	21.9M	23.0M	21.6M	23.9M	27.5M	18.6M
Net Tangible Assets	(64.5M)	(47.4M)	169.4M	136.9M	157.4M	165.2M
Accounts Payable	3.0M	3.2M	3.5M	3.2M	3.7M	2.5M
Other Assets	44K	61K	103K	1.0	0.9	0.86
Retained Earnings Total Equity	(970.1M)	(1.0B)	(1.1B)	(1.2B)	(1.1B)	(1.0B)
Accumulated Other Comprehensive Income	(48.2M)	(48.3M)	(50.5M)	(48.4M)	(43.6M)	(41.4M)
Property Plant Equipment	8.7M	6.9M	6.0M	5.1M	5.8M	4.5M
Current Deferred Revenue	5.9M	7.6M	16.5M	11.8M	13.6M	14.2M
Capital Surpluse	55.2M	60.8M	65.5M	72.4M	83.3M	53.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Arbutus Stock Analysis

When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arbutus Historical Balance Sheet

Arbutus Biopharma Inventory

(1.52 Million)

About Arbutus Balance Sheet Analysis

Arbutus Biopharma Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Arbutus Biopharma balance sheet Correlations

Arbutus Biopharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Arbutus Biopharma balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Arbutus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Liab	+ 0.99	Non Current Liabilities Total
Total Liab	+ 0.97	Total Assets
Other Liab	+ 0.97	Total Assets
Non Current Liabilities Total	+ 0.97	Non Current Assets Total

Cash	- 0.99	Net Debt
Common Stock	- 0.98	Other Stockholder Equity
Common Stock Total Equity	- 0.92	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings
Short Term Investments	- 0.83	Retained Earnings
Property Plant And Equipment Gross	- 0.8	Retained Earnings